Quels sont les principaux facteurs de risque pour l'artère vertébrale ?
Les facteurs incluent l'hypertension, le tabagisme, le diabète et l'hyperlipidémie.
HypertensionDiabèteHyperlipidémie
#2
Comment l'âge influence-t-il les maladies de l'artère vertébrale ?
Le risque augmente avec l'âge en raison de l'athérosclérose et de la fragilité vasculaire.
ÂgeAthéroscléroseFragilité vasculaire
#3
Quel rôle joue le diabète dans les maladies vasculaires ?
Le diabète augmente le risque de maladies vasculaires, y compris celles de l'artère vertébrale.
DiabèteMaladies vasculairesRisque
#4
Comment le stress affecte-t-il la santé vasculaire ?
Le stress chronique peut contribuer à l'hypertension et à d'autres problèmes vasculaires.
StressHypertensionSanté vasculaire
#5
Quels comportements augmentent le risque de maladies de l'artère vertébrale ?
Le tabagisme, une mauvaise alimentation et le manque d'exercice augmentent le risque.
Comportements à risqueTabagismeAlimentation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Artère vertébrale : Questions médicales les plus fréquentes",
"headline": "Artère vertébrale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Artère vertébrale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-14",
"dateModified": "2025-05-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Artère vertébrale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Artères",
"url": "https://questionsmedicales.fr/mesh/D001158",
"about": {
"@type": "MedicalCondition",
"name": "Artères",
"code": {
"@type": "MedicalCode",
"code": "D001158",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A07.015.114"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Artère vertébrale",
"alternateName": "Vertebral Artery",
"code": {
"@type": "MedicalCode",
"code": "D014711",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "R Shane Tubbs",
"url": "https://questionsmedicales.fr/author/R%20Shane%20Tubbs",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Tulane University School of Medicine, New Orleans, USA."
}
},
{
"@type": "Person",
"name": "Joe Iwanaga",
"url": "https://questionsmedicales.fr/author/Joe%20Iwanaga",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Tulane University School of Medicine, New Orleans, USA."
}
},
{
"@type": "Person",
"name": "Philippe Gailloud",
"url": "https://questionsmedicales.fr/author/Philippe%20Gailloud",
"affiliation": {
"@type": "Organization",
"name": "Division of Interventional Neuroradiology, The Johns Hopkins Hospital, 1800 E Orleans Street, Baltimore, MD, 21287, USA. phg@jhmi.edu."
}
},
{
"@type": "Person",
"name": "Ali Harati",
"url": "https://questionsmedicales.fr/author/Ali%20Harati",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Klinikum Dortmund, Dortmund, Nordrhein-Westfalen, Germany."
}
},
{
"@type": "Person",
"name": "Dominik Zeh",
"url": "https://questionsmedicales.fr/author/Dominik%20Zeh",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Klinikum Dortmund, Dortmund, Nordrhein-Westfalen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.",
"datePublished": "2024-05-27",
"url": "https://questionsmedicales.fr/article/38802765",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12885-024-12383-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Online adaptive planning methods for intensity-modulated radiotherapy.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37068488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1088/1361-6560/accdb2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37423227",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/S1470-2045(23)00265-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy.",
"datePublished": "2022-08-05",
"url": "https://questionsmedicales.fr/article/35930751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1200/OP.22.00104"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/38019227",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2023.24.11.3697"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système cardiovasculaire",
"item": "https://questionsmedicales.fr/mesh/D002319"
},
{
"@type": "ListItem",
"position": 3,
"name": "Vaisseaux sanguins",
"item": "https://questionsmedicales.fr/mesh/D001808"
},
{
"@type": "ListItem",
"position": 4,
"name": "Artères",
"item": "https://questionsmedicales.fr/mesh/D001158"
},
{
"@type": "ListItem",
"position": 5,
"name": "Artère vertébrale",
"item": "https://questionsmedicales.fr/mesh/D014711"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Artère vertébrale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Artère vertébrale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Artère vertébrale",
"description": "Comment diagnostiquer une occlusion de l'artère vertébrale ?\nQuels tests sont utilisés pour évaluer l'artère vertébrale ?\nQuels signes indiquent une dissection de l'artère vertébrale ?\nComment évaluer la circulation sanguine dans l'artère vertébrale ?\nQuels symptômes nécessitent un examen de l'artère vertébrale ?",
"url": "https://questionsmedicales.fr/mesh/D014711?mesh_terms=Radiotherapy,+Intensity-Modulated#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Artère vertébrale",
"description": "Quels sont les symptômes d'une insuffisance de l'artère vertébrale ?\nComment se manifeste une dissection de l'artère vertébrale ?\nQuels signes neurologiques peuvent indiquer un problème ?\nQuels symptômes sont associés à un AVC vertébrobasilaire ?\nComment reconnaître une compression de l'artère vertébrale ?",
"url": "https://questionsmedicales.fr/mesh/D014711?mesh_terms=Radiotherapy,+Intensity-Modulated#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Artère vertébrale",
"description": "Comment prévenir les maladies de l'artère vertébrale ?\nQuels exercices sont bénéfiques pour l'artère vertébrale ?\nComment le tabagisme affecte-t-il l'artère vertébrale ?\nPourquoi est-il important de contrôler la pression artérielle ?\nQuels aliments favorisent la santé des artères ?",
"url": "https://questionsmedicales.fr/mesh/D014711?mesh_terms=Radiotherapy,+Intensity-Modulated#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Artère vertébrale",
"description": "Quels traitements sont disponibles pour une dissection de l'artère vertébrale ?\nComment traiter une occlusion de l'artère vertébrale ?\nQuels médicaments sont utilisés pour traiter les troubles vertébraux ?\nQuand une intervention chirurgicale est-elle nécessaire ?\nQuels sont les traitements non chirurgicaux pour l'artère vertébrale ?",
"url": "https://questionsmedicales.fr/mesh/D014711?mesh_terms=Radiotherapy,+Intensity-Modulated#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Artère vertébrale",
"description": "Quelles sont les complications d'une dissection de l'artère vertébrale ?\nQuels risques sont associés à une occlusion de l'artère vertébrale ?\nComment une compression de l'artère vertébrale peut-elle affecter la santé ?\nQuelles sont les conséquences d'une insuffisance vertébrale ?\nQuels sont les effets à long terme d'une maladie de l'artère vertébrale ?",
"url": "https://questionsmedicales.fr/mesh/D014711?mesh_terms=Radiotherapy,+Intensity-Modulated#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Artère vertébrale",
"description": "Quels sont les principaux facteurs de risque pour l'artère vertébrale ?\nComment l'âge influence-t-il les maladies de l'artère vertébrale ?\nQuel rôle joue le diabète dans les maladies vasculaires ?\nComment le stress affecte-t-il la santé vasculaire ?\nQuels comportements augmentent le risque de maladies de l'artère vertébrale ?",
"url": "https://questionsmedicales.fr/mesh/D014711?mesh_terms=Radiotherapy,+Intensity-Modulated#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une occlusion de l'artère vertébrale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un angiogramme cérébral ou une IRM peut révéler une occlusion."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'artère vertébrale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie Doppler et l'IRM sont couramment utilisés pour évaluer cette artère."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une dissection de l'artère vertébrale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs cervicales soudaines et des symptômes neurologiques peuvent indiquer une dissection."
}
},
{
"@type": "Question",
"name": "Comment évaluer la circulation sanguine dans l'artère vertébrale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angiographie par résonance magnétique permet d'évaluer la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un examen de l'artère vertébrale ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vertiges, des troubles de la vision ou des maux de tête sévères justifient un examen."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une insuffisance de l'artère vertébrale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des troubles de l'équilibre et des évanouissements."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une dissection de l'artère vertébrale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs cervicales, des céphalées et des symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Quels signes neurologiques peuvent indiquer un problème ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des engourdissements, des faiblesses ou des troubles de la parole peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à un AVC vertébrobasilaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des troubles de la vision et des difficultés à parler."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une compression de l'artère vertébrale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs cervicales et des symptômes neurologiques peuvent indiquer une compression."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies de l'artère vertébrale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, contrôler la pression artérielle et éviter le tabac."
}
},
{
"@type": "Question",
"name": "Quels exercices sont bénéfiques pour l'artère vertébrale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices de renforcement du cou et d'étirement peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme affecte-t-il l'artère vertébrale ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque de maladies vasculaires, y compris des problèmes vertébraux."
}
},
{
"@type": "Question",
"name": "Pourquoi est-il important de contrôler la pression artérielle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon contrôle de la pression artérielle réduit le risque de maladies de l'artère vertébrale."
}
},
{
"@type": "Question",
"name": "Quels aliments favorisent la santé des artères ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fruits, légumes et acides gras oméga-3 favorise la santé vasculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour une dissection de l'artère vertébrale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des anticoagulants et, dans certains cas, une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Comment traiter une occlusion de l'artère vertébrale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des médicaments anticoagulants et des interventions endovasculaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter les troubles vertébraux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticoagulants et des anti-inflammatoires peuvent être prescrits pour ces troubles."
}
},
{
"@type": "Question",
"name": "Quand une intervention chirurgicale est-elle nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale est nécessaire en cas de dissection sévère ou d'occlusion persistante."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements non chirurgicaux pour l'artère vertébrale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements non chirurgicaux incluent la physiothérapie et la médication pour la douleur."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'une dissection de l'artère vertébrale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure un AVC, des douleurs chroniques et des déficits neurologiques."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à une occlusion de l'artère vertébrale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une occlusion peut entraîner un AVC ischémique et des complications neurologiques graves."
}
},
{
"@type": "Question",
"name": "Comment une compression de l'artère vertébrale peut-elle affecter la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des douleurs, des troubles de l'équilibre et des symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une insuffisance vertébrale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences incluent des vertiges, des évanouissements et un risque accru d'AVC."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme d'une maladie de l'artère vertébrale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des déficits neurologiques permanents et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour l'artère vertébrale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le tabagisme, le diabète et l'hyperlipidémie."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les maladies de l'artère vertébrale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque augmente avec l'âge en raison de l'athérosclérose et de la fragilité vasculaire."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le diabète dans les maladies vasculaires ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète augmente le risque de maladies vasculaires, y compris celles de l'artère vertébrale."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il la santé vasculaire ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à l'hypertension et à d'autres problèmes vasculaires."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de maladies de l'artère vertébrale ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, une mauvaise alimentation et le manque d'exercice augmentent le risque."
}
}
]
}
]
}
Radiotherapy interruption (RTI) prolongs the overall total treatment time and leads to local control loss in many cancers, but it is unclear in esophageal cancer. We aimed to evaluate the influence of...
A total of 299 patients with esophageal squamous cell carcinoma from 2017 to 2019 were retrospectively analyzed to investigate the effect of RTI on OS, PFS, and LRFS. The delayed time of radiotherapy ...
The 3-year OS, PFS, and LRFS rates were 53.0%, 42.0%, and 48.0%, respectively. The univariate and multivariate analyses showed that the delayed time > 3 days was an independent adverse prognostic fact...
There was a significant correlation between delayed time and local control of esophageal cancer. The delayed time for more than 3 days might decrease the survival outcome, and increase the local recur...
Online adaptive radiation therapy aims at adapting a patient's treatment plan to their current anatomy to account for inter-fraction variations before daily treatment delivery. As this process needs t...
Most newly diagnosed oropharyngeal and hypopharyngeal cancers are treated with chemoradiotherapy with curative intent but at the consequence of adverse effects on quality of life. We aimed to investig...
DARS was a parallel-group, phase 3, multicentre, randomised, controlled trial done in 22 radiotherapy centres in Ireland and the UK. Participants were aged 18 years and older, had T1-4, N0-3, M0 oroph...
From June 24, 2016, to April 27, 2018, 118 patients were registered, 112 of whom were randomly assigned (56 to each treatment group). 22 (20%) participants were female and 90 (80%) were male; median a...
Our findings suggest that DO-IMRT improves patient-reported swallowing function compared with standard IMRT. DO-IMRT should be considered a new standard of care for patients receiving radiotherapy for...
Cancer Research UK....
Delays in initiation of radiotherapy may contribute to inferior oncologic outcomes that are more commonly observed in minoritized populations in the United States. We aimed to examine inequities assoc...
The National Cancer Database was queried to identify the 10 cancer sites most commonly treated with IMRT. Interval to initiation of treatment (IIT) was broken into quartiles for each disease site, wit...
Among patients (n = 350,425) treated with IMRT between 2004 and 2017, non-Hispanic Black (NHB), Hispanic, and Asian patients were significantly more likely to have delayed IIT with IMRT for nearly all...
Delays in initiation of IMRT in NHB, Hispanic, and Asian patients may contribute to the known differences in cancer outcomes and warrant further investigation, particularly to further clarify the role...
Dosimetric sparing of critical swallowing structures like constrictor muscles and larynx can lead to improved functional outcomes in head and neck cancer patients treated by chemoradiation....
A total of 50 Patients with newly diagnosed, biopsy proven AJCC stage II-IV head and neck squamous cell cancers (HNSCC) were prospectively studied. 25 patients were randomized in each arm of Dysphagia...
Patients in both arms showed significant (P <0.01 or P < 0.001) improvement in MDADI (global and composite), UW-QOL and Water Swallow Test scores. However, the improvements were found significantly hi...
The Do-IMRT improves swallowing functions compared to S-IMRT in HNSCC patients treated with radical chemoradiation....
Concurrent chemoradiotherapy has long been a standardized therapy for localized advanced nasopharyngeal cancer. It is widely used in clinical applications. In contrast, NCCN guidelines highlight that ...
We searched the relevant literature in PubMed, EMBASE, and Cochrane, extracting relevant data from the searched literature. The main items extracted were hazard ratios (HRs), risk ratios (RRs) and 95%...
Our study included seven articles involving 1633 cases of stage II nasopharyngeal cancer. The survival outcomes were overall survival (OS) (HR = 1.03, 95% CI (0.71-1.49), P = 0.87), progression-free s...
In the era of intensity-modulated radiotherapy, concurrent chemoradiotherapy and radiotherapy alone have the same survival benefits, and concurrent chemoradiotherapy increases acute hematological toxi...
A planning study was performed to evaluate dosimetric differences between intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for head and neck cancer (HNC) for se...
30 patients with HNC were included, 15 treated with SIB and 15 with Seq-Boost. For all patients both VMAT and IMRT plans were completed. The planning objective for PTV was 95% of dose covering minimum...
Both techniques achieved the set objectives regarding PTV coverage and organ sparing. SIB plans presented a statistically significant better homogeneity for VMAT (p = 0.0096), while Seq-boost showed a...
VMAT shows dosimetric superiority to IMRT in some cases, however an adequate coverage of the target volumes and a suitable OAR sparing can be achieved with both techniques. Though IMRT is still the st...
The purpose of this study was to review outcomes of patients with advanced/metastatic pheochromocytoma/paraganglioma (PPGL) treated at our institution with Intensity-modulated radiotherapy (IMRT), des...
A retrospective study on patients with advanced/metastatic PPGL who received IMRT at Peking Union Medical College Hospital between 2014 and 2019. A total of 14 patients with 17 lesions were included i...
OS at 2 years was 78% for all patients. For lesions evaluated by RECIST response, at least stable disease of the target lesion was achieved in 94% and distant progression in 28.5%, with an average tim...
We have found hypofractionated IMRT effective as an additional therapy for patients with advanced primary tumors or recurrence in situ and not amenable to complete surgical resection....
Intensity-modulated radiotherapy (IMRT) is a modern precision radiotherapy technique for the treatment of the pituitary adenoma....
Aim to investigate the efficacy and toxicity of IMRT in treating Cushing's Disease (CD)....
70 of 115 patients with CD treated with IMRT at our institute from April 2012 to August 2021 were included in the study. The radiation doses were usually 45-50 Gy in 25 fractions. After IMRT, endocrin...
At a median follow-up time of 36.8 months, the endocrine remission rate at 1, 2, 3 and 5 years were 28.5%, 50.2%, 62.5% and 74.0%, respectively. The median time to remission was 24 months (95%CI: 14.0...
IMRT was a highly effective second-line therapy with low side effect profile for CD patients. Endocrine remission, tumor control and recurrence rates were comparable to previous reports on FRT and SRS...
We analyzed the patterns of lymph node (LN) failure and prognosis in patients with regional recurrent nasopharyngeal carcinoma (rNPC) alone after primary intensity-modulated radiotherapy (IMRT)....
A total of 175 patients who were treated with IMRT between 2010 and 2015 and who experienced regional recurrence alone were included. Recurrent LNs were re-located in the initial pretreatment imaging ...
Level IIb (49.1%, 86/175) was the most frequent recurrence site, followed by level IIa (36%), level III (18.9%), level IVa (12%), the retropharyngeal region (8%), level Va (6.9%), and the parotid regi...
In-field failure represented the main pattern of regional recurrence and out-field failure mainly occurred in the parotid gland and level Ib. Patients with regional rNPC alone had a good prognosis aft...